Clinical Trials Directory

Trials / Completed

CompletedNCT01348581

Use of Fish Skin Extracellular Matrix (ECM) to Facilitate Chronic Wound Healing

Chronic Wound Treatment With Extracellular Matrix (ECM) Scaffold Made From Fish Proteins

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
37 (actual)
Sponsor
Kerecis Ltd. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The clinical study is designed to assess the effectiveness, safety and non-immunogenicity of fish skin wound dressing extracellular matrix (ECM) in treating chronic wounds. The wound dressing is indicated for the management of difficult to heal and chronic wounds. The matrix is cut to fit the wound and is applied to the wound bed. An absorptive secondary dressing is put on top. Further dressing of the wound depends on the etiology. The indications for use are: * partial and full-thickness wounds * pressure ulcers * venous ulcers * diabetic ulcers * chronic vascular ulcers * tunneled/undermined wounds * trauma wounds (abrasions, lacerations, second-degree burns, and skin tears)

Conditions

Interventions

TypeNameDescription
DEVICEMarigen Wound DressingThe dressing is changed at least twice a week, with no more than five days between dressing changes. It is extremely important that the dressings are changed sufficiently often. On highly exuding ulcers the three or four dressing changes per week may be necessary. Duration is four weeks.

Timeline

Start date
2010-11-01
Primary completion
2012-12-01
Completion
2013-01-01
First posted
2011-05-05
Last updated
2017-03-03

Locations

1 site across 1 country: Iceland

Source: ClinicalTrials.gov record NCT01348581. Inclusion in this directory is not an endorsement.